Fear-not clinical indications-may be the driving force in women's decision-making about contralateral prophylactic mastectomy (CPM). That is the surprising conclusion from a population-based study presented by investigators from Michigan at the 2012 American Society of Clinical Oncology (ASCO) Quality Symposium in San Diego.
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Trimethoprim–sulfamethoxazole not found to increase infant birth weight in HIV cases
July 9th 2025A recent randomized trial found no significant improvement in birth weight or key birth outcomes from antenatal trimethoprim–sulfamethoxazole prophylaxis in human immunodeficiency virus-positive pregnant women.
Read More